Видео ютуба по тегу Nmosd Clinical Trials

Why do we need clinical trials in NMO?
Why do we need clinical trials in NMO?
An overview of the current treatment options for NMOSD from ACTRIMS 2024
An overview of the current treatment options for NMOSD from ACTRIMS 2024
Hot topics in NMOSD: immunological & clinical considerations
Hot topics in NMOSD: immunological & clinical considerations
Emerging Tolerization Technologies & Clinical Trials | NMOSD Grand Rounds
Emerging Tolerization Technologies & Clinical Trials | NMOSD Grand Rounds
104. Understanding clinical trial results for NMO therapies
104. Understanding clinical trial results for NMO therapies
How Do Clinical Trials Work?
How Do Clinical Trials Work?
205. Understanding Clinical Trials in NMO and TM
205. Understanding Clinical Trials in NMO and TM
Key considerations for clinicians treating NMOSD
Key considerations for clinicians treating NMOSD
2024 RNDS | NMOSD and MOGAD Clinical Trials
2024 RNDS | NMOSD and MOGAD Clinical Trials
Many Clinical Trials Underway For Treating Neuromyelitis Optica
Many Clinical Trials Underway For Treating Neuromyelitis Optica
Bruce Cree, MD, PhD, MAS: The NMOSD Landscape After the Inebilizumab Approval
Bruce Cree, MD, PhD, MAS: The NMOSD Landscape After the Inebilizumab Approval
Update: NMO Clinical Trials - 2018 NMO Patient Day
Update: NMO Clinical Trials - 2018 NMO Patient Day
Current Clinical Trials for Neuromyelitis Optica
Current Clinical Trials for Neuromyelitis Optica
Bruce Cree, MD, PhD, MAS: Inebilizumab for NMOSD Treatment
Bruce Cree, MD, PhD, MAS: Inebilizumab for NMOSD Treatment
How does clinical research benefit solving NMO?
How does clinical research benefit solving NMO?
Clinical Trial Scoreboard - NMO Patient Day 2015
Clinical Trial Scoreboard - NMO Patient Day 2015
Neuromyelitis Optica Spectrum Disorder (NMOSD) Clinical Trial Program
Neuromyelitis Optica Spectrum Disorder (NMOSD) Clinical Trial Program
2023 RNDS | Clinical trials in MOGAD, NMOSD, and more
2023 RNDS | Clinical trials in MOGAD, NMOSD, and more
Bruce Cree, MD, PhD, MAS: Insights from the N-MOmentum Study of Inebilizumab
Bruce Cree, MD, PhD, MAS: Insights from the N-MOmentum Study of Inebilizumab
Rituximab may be less effective in non-Caucasian patients with NMOSD
Rituximab may be less effective in non-Caucasian patients with NMOSD
Racial disparities among patients with NMOSD
Racial disparities among patients with NMOSD
MRI data from N-MOmentum: impact of inebilizumab on subclinical spinal lesions in NMOSD
MRI data from N-MOmentum: impact of inebilizumab on subclinical spinal lesions in NMOSD
306. NMO Studies and Clinical Trials: What Should I Know?
306. NMO Studies and Clinical Trials: What Should I Know?
Neruomyelitis Optica Treatment Making Great Strides
Neruomyelitis Optica Treatment Making Great Strides
Building Optimism in the Field of Neuromyelitis Optica
Building Optimism in the Field of Neuromyelitis Optica